On Friday, the American Diabetes Association kicked off its annual conference in San Francisco, where academics, vendors and other stakeholders congregated to unveil new study results and major announcements related to diabetes management. And while MobiHealthNews already put together a roundup featuring an opening salvo of the show’s announcements, the past few days have seen a tidal wave of new...
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.
Collected from nearly 8 million days of recorded system use and announced by Medtronic today in a press release, the new findings also suggest that this rate increased further for those who employed...
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events.
Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive urinary retention, medical device maker Medtronic announced yesterday.
Called the InterStim smart programmer and designed for use with Medtronic’s InterStim system, the product consists of a Samsung...
Medtronic has announced that it will acquire long-time partner Nutrino, an AI powered personalized nutrition platform for an undisclosed sum.
As part of the deal Medtronic will be integrating Nutrino’s AI-driven personalized insights and food database. The acquisition is set to specifically boost Medtronic’s offerings for people living with diabetes and offer the company’s predictive glycemic...
A recent study published in JAMA Surgery found that when it comes to reporting conflicts of interest in regards to compensation from medical device companies, doctors aren’t always completely forthcoming.
Researchers discovered that only 37.3 percent of publications written by a sample of doctors receiving the greatest compensation from device companies declared all relevant conflicts of...
Israel is continuing to carve out its space as a digital health hub in the Middle East. Today the Israeli government announced a $33 million grant aimed at furthering the country's foothold in digital health, specifically in biotech and medicine, according to Reuters. Medtronic, GE Healthcare, and Change Healthcare were named the three recipients of the funding; each company will get a different...
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes. Now, the companies have announced year one data suggesting that members who took advantage of the companies’ arrangement experienced fewer preventable hospital admissions when compared to members relying on multiple daily injections of insulin...
Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.
In fact, the FDA is turning to developers in the digital health space to help solve some of the country’s most difficult problems. In May, the agency announced an innovation challenge aimed at tackling the...
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant.
“It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri,” Huzefa Neemuchwala, global head of digital health solutions and AI at...
